ArticleThe Journal of infectious diseases2019

The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused by Leishmania donovani.

Sanjay Varikuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.